论文部分内容阅读
我们用维脑路通联合高压氧(HBO)治疗脑梗死后遗症患者200例,并与仅用高压氧治疗的100例进行比较,以探讨维脑路通联合高压氧治疗该症的确切疗效及疗效与前者剂量的关系。 1 资料与方法 1.1 一般资料 300例均为经CT或MRI证实的脑梗死患者(合并严重高血压病者未纳入),病程3个月～18个月,其中男182例,女118例;年龄37岁～76岁。所有病例经治疗后均遗留有不同程度的神经功能缺损,根据“伴发疾病评分标准”,“既往史评分标准”及“脑卒中主要临床神经功能缺损程度评分标准”进行评分一次,然后依据年龄、病程、梗死部位及面积,伴发疾病积分,既往史积分及主要临床神经功能缺损积分随机分为A、B、C三组各100例。
We use Venoruton in combination with hyperbaric oxygen (HBO) treatment of 200 cases of cerebral infarction sequelae, and compared with only 100 cases of hyperbaric oxygen therapy to explore the combination of hyperbaric oxygen and Venoruton in the treatment of the exact effect and efficacy With the former dose. 1 Materials and Methods 1.1 General Information 300 patients were confirmed by CT or MRI of patients with cerebral infarction (with severe hypertension were not included), duration of 3 months to 18 months, including 182 males and 118 females; age 37 years old to 76 years old. All cases were left after treatment of varying degrees of neurological deficit, according to the “concomitant disease score standards”, “past history scoring criteria” and “stroke major clinical neurological deficit score” score once, and then according to age , Course of disease, infarction site and area, concomitant disease score, past history score and major clinical neurological deficit were randomly divided into A, B, C three groups of 100 cases.